drugset / Trial / NCT00240617

Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks

NCT00240617

Phase 3 Completed 623 enrolled GlaxoSmithKline
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine the consistency of response for Treximet (formerly known as Trexima) when treating four acute migraine attacks at the mild pain phase and within 1 hour of onset of head pain.

Timeline

Start
2005-10
Primary completion
2006-06
Completion
2006-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Naproxen Small molecule
Comparator Sumatriptan Unknown

Indications